Optimization of a Stable Linker Involved DEVD Peptide-Doxorubicin Conjugate That Is Activated upon Radiation-Induced Caspase-3-Mediated Apoptosis

Seung Woo Chung, Beom Suk Lee, Jeong Uk Choi, Seong Who Kim, In-San Kim, Sang Yoon Kim, Youngro Byun

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The current study demonstrates the process of selecting an optimal structure for a caspase-3-cleavable doxorubicin prodrug that could be synthesized by simple chemistry in high yields. The prodrug was intended to activate in the presence of caspase-3, whose expression can be exogenously regulated by inducing apoptosis with radiation therapy at a specific site of interest. For this purpose, doxorubicin was conjugated with a DEVD peptide via a heterobifunctional linker. Since the active form of the prodrug comprises the linker besides doxorubicin, we tested several different linkers and selected EMCS based on the examination of its in vitro biological activities. Consequently, DEVD-cysteamide-EMCS-doxorubicin was synthesized as the final compound. According to the various in vitro and in vivo studies, the synthesized prodrug was highly selective for tumors when coupled with radiation therapy, with the added benefit of ease of production. (Figure Presented).

Original languageEnglish
Pages (from-to)6435-6447
Number of pages13
JournalJournal of Medicinal Chemistry
Volume58
Issue number16
DOIs
Publication statusPublished - 2015 Aug 27
Externally publishedYes

Fingerprint

Prodrugs
Caspase 3
Doxorubicin
Radiation
Apoptosis
Peptides
Radiotherapy
Neoplasms
In Vitro Techniques

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Optimization of a Stable Linker Involved DEVD Peptide-Doxorubicin Conjugate That Is Activated upon Radiation-Induced Caspase-3-Mediated Apoptosis. / Chung, Seung Woo; Lee, Beom Suk; Choi, Jeong Uk; Kim, Seong Who; Kim, In-San; Kim, Sang Yoon; Byun, Youngro.

In: Journal of Medicinal Chemistry, Vol. 58, No. 16, 27.08.2015, p. 6435-6447.

Research output: Contribution to journalArticle

Chung, Seung Woo ; Lee, Beom Suk ; Choi, Jeong Uk ; Kim, Seong Who ; Kim, In-San ; Kim, Sang Yoon ; Byun, Youngro. / Optimization of a Stable Linker Involved DEVD Peptide-Doxorubicin Conjugate That Is Activated upon Radiation-Induced Caspase-3-Mediated Apoptosis. In: Journal of Medicinal Chemistry. 2015 ; Vol. 58, No. 16. pp. 6435-6447.
@article{ce97dcac166d4b8785a45ee9dc8eb393,
title = "Optimization of a Stable Linker Involved DEVD Peptide-Doxorubicin Conjugate That Is Activated upon Radiation-Induced Caspase-3-Mediated Apoptosis",
abstract = "The current study demonstrates the process of selecting an optimal structure for a caspase-3-cleavable doxorubicin prodrug that could be synthesized by simple chemistry in high yields. The prodrug was intended to activate in the presence of caspase-3, whose expression can be exogenously regulated by inducing apoptosis with radiation therapy at a specific site of interest. For this purpose, doxorubicin was conjugated with a DEVD peptide via a heterobifunctional linker. Since the active form of the prodrug comprises the linker besides doxorubicin, we tested several different linkers and selected EMCS based on the examination of its in vitro biological activities. Consequently, DEVD-cysteamide-EMCS-doxorubicin was synthesized as the final compound. According to the various in vitro and in vivo studies, the synthesized prodrug was highly selective for tumors when coupled with radiation therapy, with the added benefit of ease of production. (Figure Presented).",
author = "Chung, {Seung Woo} and Lee, {Beom Suk} and Choi, {Jeong Uk} and Kim, {Seong Who} and In-San Kim and Kim, {Sang Yoon} and Youngro Byun",
year = "2015",
month = "8",
day = "27",
doi = "10.1021/acs.jmedchem.5b00420",
language = "English",
volume = "58",
pages = "6435--6447",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "16",

}

TY - JOUR

T1 - Optimization of a Stable Linker Involved DEVD Peptide-Doxorubicin Conjugate That Is Activated upon Radiation-Induced Caspase-3-Mediated Apoptosis

AU - Chung, Seung Woo

AU - Lee, Beom Suk

AU - Choi, Jeong Uk

AU - Kim, Seong Who

AU - Kim, In-San

AU - Kim, Sang Yoon

AU - Byun, Youngro

PY - 2015/8/27

Y1 - 2015/8/27

N2 - The current study demonstrates the process of selecting an optimal structure for a caspase-3-cleavable doxorubicin prodrug that could be synthesized by simple chemistry in high yields. The prodrug was intended to activate in the presence of caspase-3, whose expression can be exogenously regulated by inducing apoptosis with radiation therapy at a specific site of interest. For this purpose, doxorubicin was conjugated with a DEVD peptide via a heterobifunctional linker. Since the active form of the prodrug comprises the linker besides doxorubicin, we tested several different linkers and selected EMCS based on the examination of its in vitro biological activities. Consequently, DEVD-cysteamide-EMCS-doxorubicin was synthesized as the final compound. According to the various in vitro and in vivo studies, the synthesized prodrug was highly selective for tumors when coupled with radiation therapy, with the added benefit of ease of production. (Figure Presented).

AB - The current study demonstrates the process of selecting an optimal structure for a caspase-3-cleavable doxorubicin prodrug that could be synthesized by simple chemistry in high yields. The prodrug was intended to activate in the presence of caspase-3, whose expression can be exogenously regulated by inducing apoptosis with radiation therapy at a specific site of interest. For this purpose, doxorubicin was conjugated with a DEVD peptide via a heterobifunctional linker. Since the active form of the prodrug comprises the linker besides doxorubicin, we tested several different linkers and selected EMCS based on the examination of its in vitro biological activities. Consequently, DEVD-cysteamide-EMCS-doxorubicin was synthesized as the final compound. According to the various in vitro and in vivo studies, the synthesized prodrug was highly selective for tumors when coupled with radiation therapy, with the added benefit of ease of production. (Figure Presented).

UR - http://www.scopus.com/inward/record.url?scp=84940521055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940521055&partnerID=8YFLogxK

U2 - 10.1021/acs.jmedchem.5b00420

DO - 10.1021/acs.jmedchem.5b00420

M3 - Article

C2 - 26263187

AN - SCOPUS:84940521055

VL - 58

SP - 6435

EP - 6447

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 16

ER -